BSEIndia
      Close  
NOTICES
Notice No.   20230728-24   Notice Date   28 Jul 2023
Category   Trading   Segment   Equity
Subject   Opening of Offer to Buy – Acquisition Window (Buyback) for Anglo-French Drugs & Industries Limited
Attachments   Letter of offer AFDIL.pdf ;
Content

Trading Members and Custodians are requested to note that Securities Exchange Board of India (SEBI) has issued Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeover, Buy Back and De-listing vide its circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015 and no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016. The Exchange vide its notice no. 20170210-16 dated Feb 10, 2017, 20190424-35 dated April 24, 2019 and 20200528-32 dated 28 May 2020, 20201102-43 dated Nov 02, 2020 and 20210825-62 dated Aug 25,2021 has issued Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and Delisting.

All Market Participants are hereby informed that Anglo-French Drugs & Industries Limited (“The Company”) has announced an Offer up to 58,118 (Fifty Eight Thousand One Hundred And Eighteen) fully paid-up equity shares having face value of Rs.10/- each of the company (“equity shares”), representing 4.50% of the total number of equity shares in the paid-up equity share capital of the company, from all eligible shareholders of the company as on the record date, being July 26, 2023, on a proportionate basis, through the tender offer route, at a price of Rs.3,100/- (Rupees Three Thousand One Hundred Only) per equity share, payable in cash, for an aggregate amount not exceeding Rs.18,01,65,800/- (Rupees Eighteen Crore One Lakh Sixty Five Thousand Eight Hundred Only) (“Buy-Back Size”) excluding the transaction costs  (the “Buyback”), from August 01, 2023 to August 07, 2023.

The Company is listed on Metropolitan Stock Exchange of India Limited (MSEI).

Letter of Offer is herewith attached for perusal.

Market participants are further requested to note that this offer will be as per the SEBI circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015 and SEBI circular no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016 and Exchange notice no. 20170210-16 dated Feb 10, 2017,  20190424-35 dated April 24, 2019 and 20200528-32 dated 28 May 2020 and  the details of this Offer to Buy would be available on BSE Website – www.bseindia.com.

 

Mangesh Tayde

Deputy General Manager

Listing Sales & Ops

July 28,2023